European Society of Cardiology – 2021

Kazuma Oyama – Acute arterial events across all vascular territories in the FOURIER trial

Nicholas Marston – Cardiovascular Benefit of Lowering LDL-C Below ~1 mmol per L (40 mg per dl)

David Berg – High-Sensitivity Cardiac Troponin and the Efficacy of Dapagliflozin in Patients with Heart Failure with Reduced Ejection Fraction-An Analysis of the DAPA-HF Trial

Kazuma Oyama – Influence of Cardiovascular Drugs on the Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in DECLARE-TIMI 58

Robert Semco – Epistaxis in Anticoagulated Patients with Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

Raffaele de Caterina – Effectiveness and Safety of Edoxaban in Atrial Fibrillation Patients from the ETNA-AF Global Registry

 

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close